1. Home
  2. Live Updates
  3. Advanced breast cancer

Live Breaking News & Updates on Advanced breast cancer

Stay informed with the latest breaking news from Advanced breast cancer on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Advanced breast cancer and stay connected to the pulse of your community

Europe Recommends Three Cancer Drugs

The European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.

Japan , Japanese , Eribulin-baxter , European-medicines-agency , European-union , Committee-for-medicinal-products-human-use , Medicinal-products , Human-use , Metastatic-colorectal , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma

AstraZeneca and Daiichi Sankyo's BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment

AstraZeneca and Daiichi Sankyo's BLA for Datopotamab Deruxtecan Accepted by FDA for Advanced Breast Cancer Treatment
news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.

United-kingdom , San-antonio , Texas , United-states , Sapporo , Hokkaido , Japan , Canada , Cambridge , Cambridgeshire , China , America

New Guidance for the Treatment of Metastatic Breast Cancer

Dr Fatima Cardoso discusses the upcoming release of the "Advanced Breast Cancer (ABC) 7th International Consensus Conference Guidelines for Advanced Breast Cancer."

Portugal , Poland , Lisbon , Lisboa , Ukraine , United-states , American , Ukrainian , Fatima-cardoso , International-consensus-guidelines , European-medicines-agency , National-comprehensive-cancer-network

Screening and Treatment Reduce Breast Cancer Mortality

Simulation models indicate that breast cancer screening and treatment were associated with a 58% reduction in mortality, based on data collected between 1975 and 2019.

United-states , Surveillance-modeling-network , National-comprehensive-cancer-network-outcomes , Cancer-intervention , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma , Breast-cancer-screening , Advanced-breast-cancer , Etastatic-breast-carcinoma , Etastatic-breast-cancer

Chemo-Free Maintenance Strategies May Boost Survival in TNBC

Adapting chemo-free maintenance strategies in TNBC could offer effective disease control while improving patients' quality of life.

Singapore , United-states , South-korea , Republic-of-korea , Clinical-cancer-research , Clinical-cancer , Breast-cancer , Alignant-breast-neoplasm , Reast-carcinoma , Advanced-breast-cancer , Etastatic-breast-carcinoma

Better treatment, screening cut breast cancer deaths

Breast cancer deaths declined by a dramatic 58% between 1975 and 2019, and researchers think they can pinpoint the exact reasons for the reduction.

United-states , American , Jennifer-caswell-jin , Sylvia-plevritis , Stanford-university , Surveillance-modeling-network , Journal-of-the-american-medical-association , American-medical , Cancer-intervention , Advanced-breast-cancer , Reast-cancer-screening , Reast-cancer

Optimizing Subtyping-Based Therapy in Triple-Negative Breast Cancer

1. The median progression-free survival was improved with the pooled subtyping-based therapy group compared to the control group (11.3 months vs 5.8 months with an HR 0.44). 2. Grade 3-4 adverse events occurred in 57% of the subtyping-based group and 31% in the control group with the most common being neutropenia, anemia, and increased alanine

Rating-level , Transcriptomic-landscape , Triple-negative-breast-cancers , Advanced-breast-cancer , Precision-oncology , Triple-negative-breast-cancer , Chronic-disease , Oncology ,

New Trials in Breast Cancer: Could Your Patient Benefit?

Patients with breast cancer might be eligible to enroll in one of these clinical trials.

Kentucky , United-states , Michigan , Houston , Texas , United-kingdom , Florida , Oklahoma , New-york , Massachusetts , Spain , Memorial-sloan-kettering-cancer-center

Improving Prediction of Advanced Breast Cancer Among Women of Different Races and Ethnicities

Regular screenings may decrease the chance of diagnosis of advanced breast cancer in some women and lead to a 20% reduction in breast cancer mortality. However, the chances of being diagnosed with advanced breast cancer are higher among women who are Black or Hispanic/Latinx, overweight, or obese.

United-states , American , Karla-kerlikowske , American-joint-committee-on-cancer , Breast-cancer-surveillance-consortium , American-joint-committee , Pacific-islander , Advanced-breast-cancer , Screening , Obesity- ,

The Latest Findings on Major Breast Cancer Trials

Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.

California , United-states , Texas , Houston , Germany , San-francisco , Frankfurt , Brandenburg , Jo-chien , Gabriel-hortobagyi , University-of-california , Md-anderson-cancer-center